Latest News and Press Releases

CAMBRIDGE, U.K., April 16, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced its results for the year ended 31 December 2002 and an update on its restructuring...

CAMBRIDGE, U.K., April 16, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (Other OTC:CPHAF) (LSE:CEN) today announced that it has received and accepted, subject to shareholder approval, an offer from...

CAMBRIDGE, U.K., Dec. 19, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced that it had signed an agreement to partner CEE 03-310, its selective antagonist of...

CAMBRIDGE, U.K., Nov. 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced additional positive results from its recent Phase II trial comparing the analgesic...

CAMBRIDGE, U.K., Nov. 13, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced that it had signed an agreement to out-licence its recombinant glial growth factor...

Cambridge, U.K., Sept. 30, 2002(PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its unaudited interim financial results for the six months ended 30 June 2002. CeNeS also announced...

CAMBRIDGE, United Kingdom, Sept. 13, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) will be announcing its interim results for the six months ended 30 June 2002 on Monday 30th September...

CAMBRIDGE, U.K., Aug. 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced the spinout of its ion channel technology development business (Channelwork) as part of the ongoing...

CAMBRIDGE, United Kingdom, May 31, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced the spin-out of its cognitive testing division as part of the ongoing restructuring...

CAMBRIDGE, U.K., May 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced postive interim results from Phase II trials of CNS 5161 for neuropathic pain. Results from a single...